These guys were mentioned in the Philly Business Journal not too long ago regarding the possibility of FDA priority review vouchers which could potentially be worth a lot of money if they got approval. Not sure how true.
But this could be a steal at these levels. Who knows, but I like the risk/reward here.
News 
Market Data 
Discover 
